Yelena Janjigian and Norah Lewin Join NBC's Saturday TODAY to Discuss Cycle for Survival's 20th Anniversary
Global Partners Unite to Fund High-Risk, High-Reward Cancer Science - Cancer Grand Challenges
The One Vaccine That Could Save a Generation of Indian Women
Marty Makary: Approved a MM Drug Just 55 Days After the Application Was Filed
$1M AI Accelerator Grant for Ovarian Cancer Research - Ovarian Cancer Research Alliance
Prof. Gevorg Tamamyan Joins the London Global Cancer Week Steering Group
SURE-02 Trial: Neoadjuvant Sacituzumab Govitecan + Pembrolizumab in Muscle-Invasive Bladder Cancer
CART19-BE-02 trial: From Bench to Bedside and Beyond - Resonance
Tracks percentage of skeletal tumor burden and change from baseline in metastatic bone disease. Designed for longitudinal monitoring and documentation of disease trend.
Trend thresholds: Stable within ±10% of baseline | Increase >10% | Decrease >10%
